←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, Conditioning Regimens
Borje Andersson
MD, PhD
🏢MD Anderson Cancer Center🌐USA
Professor of Stem Cell Transplantation
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Borje Andersson developed intravenous busulfan dosing that revolutionized conditioning regimens for allogeneic HCT, reducing toxicity and improving outcomes. His pharmacokinetic-guided approach is now global standard. He leads conditioning research at MD Anderson.
Share:
🧪Research Fields 研究领域
busulfan
IV conditioning
pharmacokinetics
allogeneic HCT
AML transplant
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Borje Andersson 的研究动态
Follow Borje Andersson's research updates
留下邮箱，当我们发布与 Borje Andersson（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment